Nuclear factor of activated T cells as a driver of tumor progression and a target for precision therapy.

Khan H, Alia K, Al Dhaheri Y, Naseem M, Iratni R, Serfling E, Muhammad K.

Open source

DOI
10.1002/ame2.70251
Published
2026-07-01
Container
Animal Model Exp Med
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/ame2.70251,
  title = {Nuclear factor of activated T cells as a driver of tumor progression and a target for precision therapy.},
  author = {Khan H and  Alia K and  Al Dhaheri Y and  Naseem M and  Iratni R and  Serfling E and  Muhammad K.},
  year = {2026},
  journal = {Animal Model Exp Med},
  doi = {10.1002/ame2.70251},
  url = {https://doi.org/10.1002/ame2.70251}
}

RIS

TY  - JOUR
TI  - Nuclear factor of activated T cells as a driver of tumor progression and a target for precision therapy.
AU  - Khan H
AU  -  Alia K
AU  -  Al Dhaheri Y
AU  -  Naseem M
AU  -  Iratni R
AU  -  Serfling E
AU  -  Muhammad K.
PY  - 2026
JO  - Animal Model Exp Med
DO  - 10.1002/ame2.70251
UR  - https://doi.org/10.1002/ame2.70251
ER  - 

APA

H, K., K, A., Y, A. D., M, N., R, I., E, S., & K., M. (2026). Nuclear factor of activated T cells as a driver of tumor progression and a target for precision therapy.. Animal Model Exp Med. https://doi.org/10.1002/ame2.70251

Source records